Gossamer Bio, Inc. Ratios

Ratios Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
EBT Margin 1,227,375.00%9,417.65%1,919.99%1,207.83%1,652.58%1,330.89%-61.34%
EBIT Margin 1,241,608.33%9,604.70%1,847.17%1,111.75%1,574.88%1,360.07%-66.06%
EBITDA Margin 1,225,250.00%9,287.31%1,918.67%1,206.57%1,657.04%1,329.24%-60.63%
Operating Margin 1,241,608.33%9,604.70%1,847.17%1,111.75%1,574.88%1,360.07%-66.06%
Net Margin 1,227,375.00%9,417.65%1,919.99%1,207.83%1,652.58%1,330.89%-62.32%
FCF Margin 454,450.00%7,626.42%1,404.26%979.61%1,350.45%1,177.99%-3.82%
Efficiency
Assets Average 292.18M313.60M
Equity Average 37.42M46.13M
Invested Capital 207.79M259.36M227.01M
Asset Utilization Ratio -0.050.29
Leverage & Solvency
Interest Coverage Ratio -0.01M-96.05-18.47-11.12-15.75-13.60-5.20
Debt to Equity 1.950.20
Debt Ratio 0.090.04
Equity Ratio 0.040.200.09
Times Interest Earned -0.01M-96.05-18.47-11.12-15.75-13.60-5.20
Valuation
Enterprise Value 1,032.18M734.22M864.80M-50.66M-90.74M-89.53M
Market Capitalization 1,032.18M734.22M864.80M205.01M205.69M204.99M
Return Ratios
Return on Sales 94.18%19.20%12.08%16.53%13.31%-0.62%
Return on Capital Employed -0.76%-0.22%
Return on Assets -0.62%-0.18%
Return on Equity -4.80%-1.23%